In this EAU Podcast episode, Dr. Francesco Del Giudice (IT), Prof. Antoine van der Heijden (NL), Prof. Richard Cathomas (CH) and Dr. Laura Mertens (NL) discuss the latest updates in the 2026 EAU Guidelines on muscle-invasive bladder cancer (MIBC).

They explore major changes in perioperative treatment strategies, including the introduction of immunotherapy-based combination treatments and evolving standards for cisplatin-eligible and ineligible patients. The speakers also discuss the growing role of ctDNA, mpMRI, and multimodal imaging in diagnosis, treatment response assessment, and bladder preservation strategies.

In addition, they highlight the importance of multidisciplinary collaboration, patient-centred care, psychological support, and shared decision-making in the rapidly evolving management of MIBC.

For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.